Trial Profile
Phase II evaluation of gefitinib (ZD1839, IRESSA) in metastatic melanoma
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 20 Jan 2006
Price :
$35
*
At a glance
- Drugs Gefitinib (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
- 20 Jan 2006 New trial record.